Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TRPC3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PCSK6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
F5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
UTS2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PAF1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ATF2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PASK - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
APBA2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MTCL1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CMAS - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
SHMT2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GNA12 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MYCNOS - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
SEMA3B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ACVR1B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LOC51145 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SEPT5-GP1BB - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SMARCA5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TCF7 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on